Plus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights

    NEXT STORY
    GENFIT: new market research data highlight potential of elafibranor in PBC
    PREV STORY
    MatriSys Announces Positive Results From a Phase I Study of MSB-0221 for the Topical Treatment of Atopic Dermatitis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene to Present Clinical Data on Anti-PD-1 Antibody Tislelizumab at the European Society for Medical Oncology Immuno-Oncology Congress

    CAMBRIDGE, Mass., and BEIJING, China, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

    author_avatar
    NASDAQ Market News

    TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs

    Birinapant Shows No Activity in Randomized Phase 2 MDS Study SHAPE Shows Clinical Benefit ...

    author_avatar
    NASDAQ Market News

    Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics

    author_avatar
    NASDAQ Market News